Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boogaerts

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
Application of the International Prognostic Scoring System for myelodysplastic syndromesB Maes, P Meeus, L Michaux, et al.
Leukemia|September 7, 2007
Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40-CD40L interactions with T helper cellsS Meers, A Kasran, L Boon, et al.
Leukemia|February 16, 2007
A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classificationE Verburgh, R Achten, V J Louw, et al.
Cancer Genetics and Cytogenetics|June 1, 1984
Translocation t(3;17)(q26;q22): a marker of acute disease in myeloproliferative disorders?C Mecucci, J L Michaux, A Broeckaert-Van Orshoven, et al.
Journal of Clinical Microbiology|September 17, 1999
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive AspergillosisJ Maertens, J Verhaegen, H Demuynck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
Granulocyte growth factors: achieving a consensusM Boogaerts, F Cavalli, H Cortés-Funes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1989
In vitro and in vivo evaluation of granulocyte labeling with [99mTc]d,1-HM-PAOL Mortelmans, S Malbrain, J Stuyck, et al.
Hematologic Pathology|January 1, 1991
Update on the prognostic implication of morphology, histology, and karyotype in primary myelodysplastic syndromesG Verhoef, C De Wolf-Peeters, S Kerim, et al.
Genes, Chromosomes & Cancer|August 19, 1999
Molecular cytogenetics localizes two new breakpoints on 11q23.3 and 21q11.2 in myelodysplastic syndrome with t(11;21) translocationI Wlodarska, L Selleri, R La Starza, et al.
Cancer Genetics and Cytogenetics|May 1, 1987
Chromosome studies in patients with Philadelphia chromosome-positive chronic myeloid leukemia submitted to bone marrow transplantation--results of a European Cooperative StudyA Zaccaria, G Rosti, N Testoni, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
Application of the International Prognostic Scoring System for myelodysplastic syndromesB Maes, P Meeus, L Michaux, et al.
Leukemia|September 7, 2007
Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40-CD40L interactions with T helper cellsS Meers, A Kasran, L Boon, et al.
Leukemia|February 16, 2007
A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classificationE Verburgh, R Achten, V J Louw, et al.
Cancer Genetics and Cytogenetics|June 1, 1984
Translocation t(3;17)(q26;q22): a marker of acute disease in myeloproliferative disorders?C Mecucci, J L Michaux, A Broeckaert-Van Orshoven, et al.
Journal of Clinical Microbiology|September 17, 1999
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive AspergillosisJ Maertens, J Verhaegen, H Demuynck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
Granulocyte growth factors: achieving a consensusM Boogaerts, F Cavalli, H Cortés-Funes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1989
In vitro and in vivo evaluation of granulocyte labeling with [99mTc]d,1-HM-PAOL Mortelmans, S Malbrain, J Stuyck, et al.
Hematologic Pathology|January 1, 1991
Update on the prognostic implication of morphology, histology, and karyotype in primary myelodysplastic syndromesG Verhoef, C De Wolf-Peeters, S Kerim, et al.
Genes, Chromosomes & Cancer|August 19, 1999
Molecular cytogenetics localizes two new breakpoints on 11q23.3 and 21q11.2 in myelodysplastic syndrome with t(11;21) translocationI Wlodarska, L Selleri, R La Starza, et al.
Cancer Genetics and Cytogenetics|May 1, 1987
Chromosome studies in patients with Philadelphia chromosome-positive chronic myeloid leukemia submitted to bone marrow transplantation--results of a European Cooperative StudyA Zaccaria, G Rosti, N Testoni, et al.
Pageof 11